Regeneron Pharmaceuticals, Inc.
Tropism-Modified Recombinant Viral Particles and Uses Thereof for the Targeted Introduction of Genetic Material into Human Cells

Last updated:

Abstract:

Provided herein are compositions and methods for redirecting recombinant viral capsid particles via a specific protein:protein binding pair that forms an covalent, e.g., isopeptide, bond to display a targeting ligand on the capsid protein, wherein the targeting ligand specifically binds a cell surface marker expressed on the cell of interest.

Status:
Application
Type:

Utility

Filling date:

27 Jun 2018

Issue date:

7 May 2020